NCT03813303

Brief Summary

Colonoscopy is an important diagnostic and therapeutic tool in colon disorders. Different drugs and levels of sedation can be used in its accomplishment. There is no consensus on which is the ideal. The aim of this study was to compare the post anesthetic recovery time between patients deeply sedated with midazolam and propofol or fentanyl and propofol. 50 American Society of Anesthesiologist physical state (ASA) I and II candidates elective colonoscopy at Luxembourg Hospital were divided into two groups A) midazolam and propofol or B) fentanyl and propofol. Time of examination, post anesthetic recovery and discharge at home, intercurrence and propofol consumption were compared.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Mar 2018

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 27, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

January 23, 2019

Completed
Last Updated

January 23, 2019

Status Verified

January 1, 2019

Enrollment Period

3 months

First QC Date

December 27, 2018

Last Update Submit

January 20, 2019

Conditions

Keywords

ColonoscopyAnesthesiaFentanylMidazolamPropofol

Outcome Measures

Primary Outcomes (1)

  • Recovery time

    The main objective was to compare post-anesthetic recovery times, defined as a score greater than or equal to 9 on the Aldrete scale, in patients submitted to two sedation regimens: midazolam with propofol or fentanyl with propofol. Aldrete scale is a post anesthesic recovery scale that ranges from 0 to 10, meaning complete recovery in values above nine.

    An average of two hours after the termination of the procedure.

Study Arms (2)

Midazolam group

ACTIVE COMPARATOR

Midazolam and Propofol administered for sedation in colonoscopy elective patients by anesthesiologist . Complications and procedure and recovery times were recorded for comparison with the Fentanyl group.

Drug: MidazolamDrug: Propofol

Fentanyl group

ACTIVE COMPARATOR

Fentanyl and Propofol administered for sedation in colonoscopy elective patients by anesthesiologist .Complications and procedure and recovery times have were recorded for comparison with the Midazolam group.

Drug: FentanylDrug: Propofol

Interventions

Administration of midazolam by anesthesiologist for sedation.

Midazolam group

Administration of fentanyl by anesthesiologist for sedation.

Fentanyl group

Administration of propofol by anesthesiologist for sedation.

Fentanyl groupMidazolam group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I and II physical status patients scheduled for elective colonoscopy.

You may not qualify if:

  • BMI less than 17 or over 30
  • allergy to any medication used,
  • cognitive difficulty,
  • psychiatric disorder,
  • hospitalization,
  • chronic use of opioids.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Luxemburgo Hospital

Belo Horizonte, Minas Gerais, 30380-472, Brazil

Location

MeSH Terms

Interventions

MidazolamFentanylPropofol

Intervention Hierarchy (Ancestors)

BenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsPiperidinesHeterocyclic Compounds, 1-RingPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Renato Gomez

    Federal University of Minas Gerais

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

December 27, 2018

First Posted

January 23, 2019

Study Start

March 20, 2018

Primary Completion

June 25, 2018

Study Completion

June 25, 2018

Last Updated

January 23, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations